Poland
# |
Name |
Gross Profit Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
79.49%
|
Dec. 31, 2023 | USD 11.11 | -3.75% |
|
Poland |
|
2 |
75.54%
|
Dec. 31, 2023 | USD 2.34 | 1.69% |
|
Poland |
|
3 |
62.54%
|
Dec. 31, 2023 | USD 7.78 | -9.75% |
|
Poland |
|
4 |
60.00%
|
Dec. 31, 2023 | USD 1.05 | -1.52% |
|
Poland |
|
5 |
59.40%
|
Dec. 31, 2023 | USD 1.01 | 1.23% |
|
Poland |
|
6 |
59.35%
|
Dec. 31, 2023 | USD 6.09 | -0.44% |
|
Poland |
|
7 |
52.28%
|
Dec. 31, 2023 | USD 10.54 | 0.97% |
|
Poland |
|
8 |
40.11%
|
Dec. 31, 2023 | USD 0.77 | 0.43% |
|
Poland |
|
9 |
33.33%
|
Dec. 31, 2023 | USD 1.85 | -0.17% |
|
Poland |
|
10 |
2.07%
|
Dec. 31, 2023 | USD 2.77 | 1.63% |
|
Poland |
|
11 |
-99.14%
|
Dec. 31, 2023 | USD 9.29 | -3.28% |
|
Poland |
|
12 |
-265.89%
|
Dec. 31, 2023 | USD 40.10 | -0.57% |
|
Poland |
|
13 |
-2,709.47%
|
Dec. 31, 2023 | USD 3.73 | -0.03% |
|
Poland |
|
14 |
-3,913.67%
|
Dec. 31, 2023 | USD 0.79 | 1.05% |
|
Poland |
|
15 |
-79,300.00%
|
Dec. 31, 2023 | USD 1.74 | 1.31% |
|
Poland |
|
16 |
-1,645,575.00%
|
Dec. 31, 2023 | USD 2.23 | 1.07% |
|
Poland |
The Biotechnology company in Poland with the highest Gross Profit Margin is Selvita S.A. (Warsaw Stock Exchange: SLV.WA) at 79.49%.
The Biotechnology company in Poland with the lowest Gross Profit Margin is Molecure S.A. (Warsaw Stock Exchange: MOC.WA) at -1,645,575.00%.
The top 10 Biotechnology companies in Poland by Gross Profit Margin are Selvita S.A., Mabion S.A., Ryvu Therapeutics S.A., Synthaverse S.A., Pharmena S.A., Celon Pharma S.A., Captor Therapeutics Spolka Akcyjna, BIOTON S.A., Medinice S.A. and BioMaxima S.A..
The bottom 10 Biotechnology companies in Poland by Gross Profit Margin are Molecure S.A., Genomtec S.A., NanoGroup S.A., Pure Biologics Spólka Akcyjna, Scope Fluidics S.A., Poltreg S.A., BioMaxima S.A., Medinice S.A., BIOTON S.A. and Captor Therapeutics Spolka Akcyjna.